Comparison of the short-term effects of dienogest and oral contraceptives on pain and quality of life in women with endometriosis: a systematic review and meta-analysis [PDF]
BMC Women's HealthObjective To compare the short-term effects of dienogest and oral contraceptives (OCPs) on pain and quality of life in women with endometriosis. Method The databases including PubMed, Cochrane Library, Embase, Web of Science, CNKI, and Wanfang Database ...
Yanpin Gu +4 more
doaj +2 more sources
Cost-effectiveness of dienogest compared to gonadotropin releasing hormone agonists for the management of endometriosis in Vietnam [PDF]
Cost Effectiveness and Resource AllocationObjectives Endometriosis-related dysmenorrhea and pelvic pain impose significant economic and quality-of-life burdens. This study evaluated the cost-effectiveness of dienogest compared to gonadotropin-releasing hormone agonists (GnRH-a) for managing ...
Mai Thi Tuyet Kieu +2 more
doaj +2 more sources
Non-inferiority study to compare the efficacy of relugolix with dienogest for endometriosis-associated pain and usefulness of administering relugolix prior to dienogest (READY study): study protocol for a multicenter randomized controlled study [PDF]
TrialsBackground Endometriosis presents as endometrial tissue growths outside the uterine cavity with its major symptoms including dysmenorrhea and infertility.
Fuminori Taniguchi +4 more
doaj +2 more sources
Long-term clinical outcomes of dienogest for perimenopausal women with symptomatic adenomyosis [PDF]
Scientific ReportsWe aimed to evaluate the successful long-term use of dienogest for the management of pelvic pain and bleeding control in perimenopausal women with symptomatic adenomyosis using real-world data. All women aged ≥ 40 years with adenomyosis who complained of
Chi-Hau Chen +5 more
doaj +2 more sources
Dienogest vs. combined oral contraceptive: A systematic review and meta‐analysis of efficacy and side effects to inform evidence‐based guidelines [PDF]
Acta Obstetricia et Gynecologica ScandinavicaIntroduction Dienogest is a synthetic fourth‐generation progestin that has been approved for the medical treatment of endometriosis, and its efficacy on pain symptoms and quality of life is well established even in the long term.
Ilaria Piacenti +8 more
doaj +2 more sources
Manajemen Jangka Panjang Endometriosis: Dapatkah Progestin Menjadi Andalan?
Obgynia, 2023 Latar belakang: pada tahun 2014 The Practice Committee of The American Society of Reproductive Medicine menyebutkan bahwa endometriosis merupakan penyakit kronis yang memerlukan penanganan jangka panjang dengan titik berat pada terapi medikamentosa ...
Hartanto Bayuaji
doaj +1 more source
The Effects of Cabergoline Compared to Dienogest in Women with Symptomatic Endometrioma
Fertility & Reproduction, 2021 Background: New vessel formation or neovascularization has been recognized as a feature of endometriosis. Treatment with cabergoline suppresses cell proliferation and vascular-endothelial-growth-factor-mediated angiogenesis, thereby promoting regression ...
Mehnaz Mustary Shume +5 more
doaj +1 more source
Women's Health, 2020 Administration of Dienogest prior to hysteroscopic polypectomy is empirically performed, but the physiological effects of Dienogest on endometrial polyps are unclear.
Kei Inaba +6 more
doaj +1 more source
Indonesian Journal of Obstetrics and Gynecology, 2020 Objective: Comparing therapeutic effectiveness, safety profile, and adherence between Dienogest and postoperative Leuprolide Acetate in women with endometriosis who underwent laparoscopy.
Joko P. Purwanto +3 more
doaj +1 more source
Gynecology Obstetrics & Reproductive Medicine, 2020 Objective: Endometriosis is a common gynecological condition that affects many women of reproductive age worldwide and is a major cause of pain and infertility.
Tolga Karacan +4 more
doaj +1 more source